Health Alerts

If you don’t mind, I am going to keep a running tabulation on all the drugs that harm, while passing the info on to you all.

http://www.nytimes.com/2012/10/03/health/meningitis-cases-are-linked-to-steroid-injections.html?_r=0

Meningitis Cases Are Linked to Steroid Injections in Spine
By DENISE GRADY
Published: October 2, 2012

===============

http://search.yahoo.com/search?p=steroids+giving+meningitis&ei=UTF-8&fr=moz35

VN:R_U [1.9.22_1171]
Rating: 0 (from 0 votes)

Author: Uniformityville_horror

"http://search.eurekalert.org/e3/query.html?qt=green+tea&pw=100.101%25"

60 thoughts on “Health Alerts”

  1. http://www.bloomberg.com/news/articles/2016-03-14/how-gut-bacteria-are-shaking-up-cancer-research
    How Gut Bacteria Are Shaking Up Cancer Research

    I am going to present the url I used to get started.
    http://www.healthlady.com/BlogRetrieve.aspx?PostID=515177&A=SearchResult&SearchID=3436062&ObjectID=515177&ObjectType=55

    I just expanded the fermenting from there. It is probably a good idea to do something.

    Everyday, you MUST (!!!) do something to prevent cancer.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  2. alteration:
    oh, I did a repeat, doing it because I didn’t quite understand just how this works. So sorry.

    yet another amendment:
    I will put this here so it isn’t such a grand waste of space.

    Public Release: 14-Mar-2016, http://www.eurekalert.org/pub_releases/2016-03/w-mcs030916.php
    Many cancer survivors experience financial burdens

    Health and quality of life negatively affected
    ——–

    It is just so much better if you prevent cancer, … doing something to prevent every single day.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  3. Alcohol is a drug, right? Well, tonight I am using it as one.

    my recipe for the best martini:

    Get a container 2/3rds filled with ice. Add a few drops of Jagermeister (umlaut omitted). Add gin, not top shelf as top shelf is too attention-getting and will mask the flavor I will next add to this recipe). Let the gin set in ice for a minute. In your drinking vessel, add two nasturtiums, preferable one yellow and one orange. Pour the gin, straining out the ice, over the nasturtiums, one minute setting for flower flavor, and then serve.

    William Burroughs owned a martini bar here. I think Jim, his last lover, owns it now. It is still in existence. Met him, Jim, but he didn’t make note of me. But the bar doesn’t have this recipe. I made it up. I love gin. My body loves juniper berries, raw, topical and oral, and in gin. Need to slow down so I can sleep. Alcohol used to depress. Go figure.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  4. This is not an alert. But it is an upcoming health issue:

    http://www.techwench.com/scientists-invent-oxygen-particle-that-if-injected-allows-you-to-live-without-breathing/

    Scientists Invent Oxygen Particle That If Injected, Allows You To Live Without Breathing

    The implications and possibilities of this are massive if you imagine just right. Imagine botht he good and bad. If it can be used for wrong reasons, you know it is OUR OWN government that will do it.

    Dick Cheney living to be 200 years old is NOT at all a desirable concept.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  5. Articles:

    New dust-sized implants can track everything in your body
    by Chuck Bednar
    Read more at http://www.redorbit.com/news/health/1113415309/fitness-tracking-implants-080316/#LvLBYodCpJGAwr8M.99

    UK doctors complete first ever double hand transplant
    by Brett Smith
    Read more at http://www.redorbit.com/news/health/1113415123/double-hand-transplant-072216/#6UwmcuOyQPttlmf8.99

    This one comes with a personal story. In nursing school clinicals, I was taking care of a man who had an injury where he had two hands one minute and the next minute they were gone, a railroad employee accident. Can’t tell you how many mistakes I made with him, like handing him his pills while he reached for them, setting up his bath only to find that he couldn’t do it himself. Just crazy to try and have no hands, and to care for someone who didn’t have hands. I keep looking for him to be one of the new double transplant experiments.

    Of course you all have seen the article about flossing not proven to be effective. What else are they, the ADA, lying to us about?

    There is one more article that I want you all to see and know. But I cannot find it just now.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  6. Just in case your memory isn’t that good!
    Pfizer guilty of Fraud!!
    https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history


    FOR IMMEDIATE RELEASE
    Wednesday, September 2, 2009
    Justice Department Announces Largest Health Care Fraud Settlement in Its History

    Pfizer to Pay $2.3 Billion for Fraudulent Marketing

    WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together “Pfizer”) have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department announced today.”

    The Truth About the Drug Companies Lecture – Dr. Marcia Angell

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  7. Sorry I was so late getting this out.

    I have been bitching about fluoroquinolones for years now. On my medical records, I have it listed as allergy because there is no place for drug preferences.

    Clueless FDA finally found a clue!

    Imagine, you go to the Dr. for a minor infection, follow the druge regimen and become disabled due to taking the antibiotic. I sure do wonder about how many people had this happen, how much disability this drug created.

    It melts cartilage !!!!!!!!!!!!!!!!!!!!!!!!

    quote
    http://www.empr.com/safety-alerts-and-recalls/fda-updated-warnings-for-antibiotic-class/article/511949/
    July 26, 2016
    FDA: Updated Warnings for Antibiotic Class

    The association of serious side effects has led to a revision of fluoroquinolone guidelines
    The association of serious side effects has led to a revision of fluoroquinolone guidelines

    The Food and Drug Administration (FDA) has approved changes to the drug labeling for fluoroquinolone antibacterials for systemic use. This class of drugs has been associated with disabling and potentially permanent side effects of the tendons, muscles, joints, nerves, and central nervous system (CNS) that can simultaneously occur in the patient.

    Currently available fluoroquinolones include: Avelox (moxifloxacin), Cipro (ciprofloxacin), Cipro XR (ciprofloxacin extended-release), Factive (gemifloxacin), Levaquin (levofloxacin), and Ofloxacin.

    end of quote

    Rant: Big Pharms lobby our Congressmen. They demand changes to the law, legislation to protect them from excessive law suits. They profile our Dr.s. They buy out competition and disappear drugs or treatment processes that really work to protect their interest. This country is way, way out of whack. Fire them all, the MFs.

    If you have an illness, it is time to save yourself, the authentic company, not the imitation: http://phoenixtears.ca

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  8. If you are depressed, make a major life change. That will shock you out of it.
    AND … Psychology Today had an article in the mid-90’s that stated that it was normal to have 10 down days a month. Anyway, the recent releases on antidepressants.

    the Fluoro is the culprit in these drugs. But hey, dope America, and then complain because Americans just are not thinking right.

    quoted from here on out.

    October 14, 2016 by Pam Harrison | Medscape
    SSRIs Disrupt Sleep in the Elderly, May Contribute to Dementia
    http://www.mentalhealthexcellence.org/ssris-disrupt-sleep-in-the-elderly-may-contribute-to-dementia/
    Antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), can significantly disrupt sleep architecture in elderly patients and may contribute to early signs of neurodegeneration that can progress to dementia, new research shows.

    “We take into account other side effects of antidepressants, including weight gain and sexual side effects, but we are less concerned about sleep, especially when we use the SSRIs,” Muhammad Tahir, MD, psychiatry resident, SUNY Upstate Medical University, Syracuse, New York, told Medscape Medical News.

    “But the SSRIs increase sleep latency in the elderly and decrease REM [rapid eye movement] sleep duration and are also associated with REM sleep behavioral disorders, including nightmares,” he added.

    “So our literature review suggests that we should be careful about using SSRIs in the elderly population and not underestimate the effectiveness of psychotherapy and other holistic care approaches for the elderly,” Dr Tahir said.

    The study was presented here at the Institute of Psychiatric Services (IPS): The Mental Health Services 2016 Conference.

    The literature review included 10 studies published within the past 5 years. The studies included systemic reviews, retrospective studies, and prospective studies, and patients had to be at least 50 years of age and receiving an antidepressant, largely an SSRI, for the treatment of depression.

    Analyses revealed that not only did the SSRIs in particular change sleep architecture in older patients, they also appeared to increase the risk for REM behavioral disorders.

    REM sleep behavioral disorders are characterized by normal brain activity, but the body is agitated and is not sleeping. This may be an early sign of neurodegeneration, said Dr Tahir.

    Changes in the sleep architecture brought on by antidepressant therapy may result in agitation, Dr Tahir noted, which may prompt further treatment with further side effects.

    Unfortunately, there is little evidence to support the use of any treatment other than the SSRIs for depression in the elderly.

    Both the tricyclic antidepressants and the monoamine oxidase inhibitors are associated with too many side effects, especially in the elderly, and are generally not used in older patients.

    Benzodiazepines in turn are associated with an increased risk for falls and again are inappropriate for use in the elderly.

    Dr Tahir suggested that psychiatrists screen their elderly patients for any signs and symptoms of neurodegenerative disorders and, if an SSRI is prescribed, ask detailed questions about sleep quality on all follow-up visits.

    SSRI Dosing Important

    Commenting on the findings for Medscape Medical News, Peter Yellowlees, MD, professor of psychiatry, University of California, Davis, said the analysis, though interesting, does not include information on the doses of the SSRIs used in the studies that were included for review.

    “In the elderly, these doses should be a maximum of half of the usual dose prescribed for younger patients,” Dr Yellowlees observed.

    As for the possible association between SSRI use and neurodegenerative disease, Dr Yellowlees also noted that SSRIs are not necessarily causative.

    “Rather, it may simply be that in the early stages of these diseases, depression and agitation are more common, and hence antidepressants are more commonly prescribed,” he noted.

    In fact, the same association has been reported between the benzodiazepines and neurodegenerative disease that has been reported in the new study with respect to SSRIs, Dr Yellowlees pointed out.

    “The jury is definitely out on the connection between degenerative disorders and medications, but in my view, there is not a lot of evidence to suggest that there is a causative link, although there does seem to be an association,” Dr Yellowlees suggested.

    “The key issue here is that depression in the elderly is common and can be debilitating and is very treatable with both medications in lower doses than usually prescribed in younger patients along with behavioral interventions.”

    Dr Tahir and Dr Yellowlees have disclosed no relevant financial relationships.

    Institute of Psychiatric Services (IPS): The Mental Health Services 2016 Conference. Abstract 14. Presented October 7, 2016.

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)
  9. quote
    Statin Use Linked to Increased Parkinson’s Risk
    Nancy A. Melville
    October 26, 2016
    http://www.medscape.com/viewarticle/870996

    http://www.medscape.com

    Statin Use Linked to Increased Parkinson’s Risk

    Nancy A. MelvilleOctober 26, 2016

    BALTIMORE — New findings from a large national claims database show the use of cholesterol-lowering statin drugs to be associated with an increased risk for Parkinson’s disease (PD), contrary to previous research suggesting the drugs have a protective effect for PD.

    “We identified 20,000 Parkinson’s disease patients and looked at whether using statins was associated with a higher or lower risk, and we found people using statins have a higher risk of the disease, so this is the opposite of what has been hypothesized,” senior author Xuemei Huang, MD, PhD, vice chair for research at Penn State College of Medicine, Hershey, Pennsylvania, told Medscape Medical News.

    While high cholesterol has been shown to have a protective effect on the risk for PD, the role of statin use has been the subject of debate.

    Among studies supporting a benefits was research published in 2012 in the Archives of Neurology showing a “modest Parkinson’s disease reduction” with the use of statins.

    In looking at the issue in a previous study of their own, Dr Huang and colleagues in fact found an increased risk associated with statin use, and they sought in the new study to further explore the association in a much larger cohort.

    For the new study, presented here at the American Neurological Association (ANA) 2016 Annual Meeting, the researchers turned to data from the MarketScan Commercial Claims and Encounters database, including information on 30,343,035 persons aged 40 to 65 years between January 1, 2008, and December 31, 2012.

    Of the subjects, 21,559 were identified as having PD on the basis of criteria of having a primary or secondary diagnosis, using anti-Parkinson’s medication, or having deep-brain stimulation surgery.

    In the cross-sectional analysis, the use of cholesterol-lowering drugs, including statins or nonstatins, was associated with a significantly higher prevalence of Parkinson’s disease (odds ratio [OR], 1.61 – 1.67; P < .0001) after adjustment for age, sex, and other comorbidities, such as hyperlipidemia, diabetes, hypertension, and coronary artery disease. For a comparative neurodegenerative group, the researchers also looked at the association of statin with diagnosis of Alzheimer's disease but found only a minimal association (OR, 1.01 - 1.12; P = .055). The associations of cholesterol-lowering medications with PD were strongest among patients with hyperlipidemia, and there were no significant differences between lipophilic or hydrophilic statins, as well as the other nonstatin cholesterol-lowering drugs, in their effect on PD risk. "We know that overall weight of the literature favors that higher cholesterol is associated with beneficial outcomes in Parkinson's disease, so it's possible that statins take away that protection by treating the high cholesterol," Dr Huang explained. "Another possibility is that statins can block not only the cholesterol synthesis but also synthesis of coenzyme Q10 that is essential for cell function." The researchers also stratified persons according to how long they had been receiving treatment by using a lagged matched case-control analysis of 2458 pairs of PD cases and controls. In the cross-sectional analysis, both statins and nonstatin cholesterol-lowering drugs were associated with PD, but in the lagged case-control analysis of treatment duration, only statins remained significantly associated with PD risk. The highest risk was linked to the earlier period after starting statins (OR, 1.93 for less than 1 year of use; 1.83 for 1 to 2.5 years; and 1.37 for 2.5 years or more; P trend < .0001). "The increased risk of Parkinson's is more likely when statins are first used, so we think it could be that the statins 'unmasked' Parkinson's," Dr. Huang said. "Namely, people may be already on the way to Parkinson's and when they use statins to control the high cholesterol, it gives Parkinson's a push to reveal its clinical symptoms. "Based on this data, we think caution should be taken before advancing statins to be protective of Parkinson's disease," she added. "The data are not clear yet." A meta-analysis published earlier this year in the journal Pharmacoepidemiology and Drug Safety suggests that one reason for the inconsistencies in evidence of the role of statins is that many studies fail to adjust for cholesterol levels. In that report, studies that did not make the adjustment showed a protective effect of statins (relative risk, 0.75), but those that did adjust for cholesterol or hyperlipidemia showed no protective effect: Those adjusting for hyperlipidemia had a relative risk of 0.91, and for cholesterol, the relative risk was 1.04. "The apparent protective effect of statins on risk of Parkinson's disease is at least partially explained by confounding by statin indication," the authors said. In addition, a separate meta-analysis published in the Journal of Neurology in 2013 suggested that there is a significant publication bias in recent literature toward reporting protective effects of statins in PD. "The current study is one of very few studies reporting potential negative effects of statin in Parkinson's disease," Dr Huang noted. The study was funded by grants from the National Institutes of Health, Pennsylvania State University College of Medicine-Milton S. Hershey Medical Center, General Clinical Research Center (GCRC), GCRC Construction, and the Center for Applied Studies in Health Economics. The authors have disclosed no relevant financial relationships. American Neurological Association (ANA) 2016 Annual Meeting. Abstract S137. Presented October 16, 2016. end of quote

    VN:R_U [1.9.22_1171]
    Rating: 0 (from 0 votes)

Leave a Reply